Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Field Tests of Genetically Modified Moths to Begin

Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway. . . . → Read More: Field Tests of Genetically Modified Moths to Begin

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Trial Shows Smartphone App Finds More Heart Disease

Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits. . . . → Read More: Trial Shows Smartphone App Finds More Heart Disease

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

3-D Printing Process Developed for Living Tissue

Researchers in the U.K. devised 3-D printing techniques for human and animal cells to produce functioning tissue with multiple types of cells. . . . → Read More: 3-D Printing Process Developed for Living Tissue

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

Faster Process Devised for Targeted Antibodies

Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies. . . . → Read More: Faster Process Devised for Targeted Antibodies

Clinical Trial Begins for Liver Dialysis Device

A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option. . . . → Read More: Clinical Trial Begins for Liver Dialysis Device

Grant Funding Automated Genome Editing System

A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique. . . . → Read More: Grant Funding Automated Genome Editing System

Device Shown to Reduce Migraine Occurrence

A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence. . . . → Read More: Device Shown to Reduce Migraine Occurrence